We've updated ourPrivacy Policyto make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read ourCookie Policyhere.

Advertisement
Webinar

High-Quality Vaccine Development Powered by Quality Control Using Agilent Fragment Analyzer System

On-Demand
Speaking at the Vaccine Research & Development 2022, Kyle Luttgeharm, PhD, Product Manager from Agilent presented their talk on IVT RNA production and
accurate and precise mRNA analysis.
Webinar

Rapid Screening and Scaled Manufacture of Immunogenic Virus-Like Particles

On-Demand
Speaking at the Vaccine Research & Development 2022, Jorge Armero Gimenez from Wageningen University & Research, presented their talk on Virus-Like Particles immunogenicity in human dendritic cells.
Webinar

Looking to the Future of Cell and Gene Therapies

On-Demand
This Technology Networks event features exclusive talks focused on the most recent and innovative developments in the world of cell and gene therapies. Our expert speakers will highlight the opportunities cell and gene therapies provide for the treatment of disease and injury, including how cell therapies are providing novel solutions for rare diseases such as Duchenne muscular dystrophy.
Webinar

Lassa Fever: A UK Outbreak in 2022

On-Demand
In this webinar, Dr. Catherine Houlihan, will describe an unrecognized case of viral hemorrhagic fever imported into the UK and the important lessons learned for the emergency clinicians, GPs, virologists, infection specialists and public health doctors.
Webinar

Plan Now or Fail Later: Why Raw Materials Matter

On-Demand
Accelerating the development of mRNA vaccines and therapeutics requires the selection and use of raw materials designed to meet critical process, scale, quality and regulatory needs. Choosing appropriate materials saves scientists both time and money.
Online Event

Vaccine Research & Development 2022

On-Demand
This inaugural online symposium will provide a unique opportunity to hear from experts within academia and industry. The focus will be given to advances and innovations that are driving vaccine R&D, with process challenges and bottlenecks also discussed.
Advertisement
Baidu